EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of probiotic supplementation on Clostridioides difficile stool concentration in hospitalized patients in coma: A preliminary study

Natalia Dowgiałło-Gornowicz, Anna Botulińska, Ewelina Sosnowska-Turek, Magdalena Garbowicz, Ewelina Zarucka, Piotr Siwik

Polish Annals of Medicine · 19.03.2026 · 33 · 53-58

DOI: 10.31648/paom/213335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Annals of Medicine, online erschienen am 19.03.2026. Verfasst von Natalia Dowgiałło-Gornowicz und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clostridioides difficile (CD) is a major healthcare-associated pathogen responsible for antibiotic-associated diarrhea and severe colitis. Probiotics have been proposed as a preventive strategy. However, data in critically ill patients remain limited.

Aim

To evaluate the effect of probiotic supplementation on CD stool concentration in patients hospitalized in coma. Material and methods This prospective, randomized preliminary study was conducted from May to August 2023 at the Department of Medical Rehabilitation “Budzik dla Dorosłych”. Fourteen patients in coma were randomized to receive either a new probiotic mixture (Labifid®, containing Bifidobacterium animalis AMT30 and Bifidobacterium breve AMT32) or standard hospital probiotics (Lactobacillus rhamnosus, Saccharomyces boulardii). Stool samples were collected at baseline, 1, 2, and 4 months afterwards. Results and Discussion Baseline CD levels were comparable between groups (2.1 × 10⁵ vs. 2.2 × 10⁶ CFU/g; p = 0.607). At 1, 2, and 4 months, patients receiving the new probiotics demonstrated significantly lower CD concentrations than controls (p = 0.032, p = 0.017, and p = 0.029, respectively). After 4 months, CD levels in the new-probiotic group fell below the detection limit. No serious adverse events were observed.

Conclusions

Supplementation with Bifidobacterium animalis and Bifidobacterium breve was associated with a significant reduction in CD stool concentration in comatose patients. However, due to the small sample size, it should be interpreted with caution.

Zitieren

APA

Dowgiałło-Gornowicz, N., Botulińska, A., Sosnowska-Turek, E., Garbowicz, M., Zarucka, E., & Siwik, P. (2026). Effect of probiotic supplementation on Clostridioides difficile stool concentration in hospitalized patients in coma: A preliminary study. Polish Annals of Medicine, 33, 53-58. https://doi.org/10.31648/paom/213335

Vancouver

Dowgiałło-Gornowicz N, Botulińska A, Sosnowska-Turek E, Garbowicz M, Zarucka E, Siwik P. Effect of probiotic supplementation on Clostridioides difficile stool concentration in hospitalized patients in coma: A preliminary study. Polish Annals of Medicine. 2026;33:53-58. doi:10.31648/paom/213335

BibTeX
@article{DowgiaoGornowicz2026,
  author = {Dowgiałło-Gornowicz, Natalia and Botulińska, Anna and Sosnowska-Turek, Ewelina and Garbowicz, Magdalena and Zarucka, Ewelina and Siwik, Piotr},
  title = {Effect of probiotic supplementation on Clostridioides difficile stool concentration in hospitalized patients in coma: A preliminary study},
  journal = {Polish Annals of Medicine},
  year = {2026},
  volume = {33},
  pages = {53--58},
  doi = {10.31648/paom/213335}
}
Kostenlos starten →